Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions
- PMID: 8398148
- DOI: 10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions
Abstract
An increased prevalence of apolipoprotein E (ApoE) epsilon 4 allele exists in late onset familial Alzheimer's disease. We found, in sporadic Alzheimer's disease, that 62% of patients possessed an ApoE-epsilon 4 allele, compared with 20% of controls. ApoE-epsilon 4/4 patients had more senile plaques (SPs) than epsilon 3/3 patients. ApoE immunoreactivity of SPs was equivalent in both groups. Two receptors bind ApoE complexes, the low density lipoprotein (LDL) receptor and the LDL receptor-related protein (LRP). In normal brain, anti-LRP antibodies strongly stained neurons and lightly stained astrocytes; anti-LDL receptor antibodies stained only the neuropil and astrocytes. In Alzheimer's disease, SPs and reactive astrocytes were also strongly LRP immunoreactive. Colocalization of ApoE and LRP to SPs implies that these molecules may be involved in metabolism of components of SPs.
Similar articles
-
Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.Ann Neurol. 1995 Feb;37(2):211-7. doi: 10.1002/ana.410370212. Ann Neurol. 1995. PMID: 7531418
-
Alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Relationship to apolipoprotein E and role in Alzheimer disease senile plaques.Ann N Y Acad Sci. 1994 Sep 10;737:88-95. doi: 10.1111/j.1749-6632.1994.tb44303.x. Ann N Y Acad Sci. 1994. PMID: 7944156 No abstract available.
-
LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.Brain Res Mol Brain Res. 2002 Jul 15;104(1):38-46. doi: 10.1016/s0169-328x(02)00203-6. Brain Res Mol Brain Res. 2002. PMID: 12117549
-
Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.Arch Neurol. 2000 May;57(5):646-50. doi: 10.1001/archneur.57.5.646. Arch Neurol. 2000. PMID: 10815129 Review.
-
Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms.Biochem Soc Symp. 2001;(67):101-9. doi: 10.1042/bss0670101. Biochem Soc Symp. 2001. PMID: 11447826 Review.
Cited by
-
Genomics of Alzheimer Disease: A Review.JAMA Neurol. 2016 Jul 1;73(7):867-74. doi: 10.1001/jamaneurol.2016.0301. JAMA Neurol. 2016. PMID: 27135718 Free PMC article. Review.
-
Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex.Front Aging Neurosci. 2016 Oct 4;8:232. doi: 10.3389/fnagi.2016.00232. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27757081 Free PMC article. Review.
-
The Human ApoE4 Variant Reduces Functional Recovery and Neuronal Sprouting After Incomplete Spinal Cord Injury in Male Mice.Front Cell Neurosci. 2021 Feb 18;15:626192. doi: 10.3389/fncel.2021.626192. eCollection 2021. Front Cell Neurosci. 2021. PMID: 33679326 Free PMC article.
-
Is the LDL receptor involved in cortical amyloid protein clearance?Neurochem Res. 2006 Jun;31(6):839-47. doi: 10.1007/s11064-006-9084-0. Epub 2006 Jul 14. Neurochem Res. 2006. PMID: 16841190 Review.
-
Remembering your A, B, C's: Alzheimer's disease and ABCA1.Acta Pharm Sin B. 2022 Mar;12(3):995-1018. doi: 10.1016/j.apsb.2022.01.011. Epub 2022 Jan 24. Acta Pharm Sin B. 2022. PMID: 35530134 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous